Professor Alexandre Loupy, specialist in multi-organ transplantation, is awarded a European Consolidator Grant by the European Research Council for excellent frontier research. On November 23, 2023, the European Research Council published the results of its call for Consolidator Grant (CoG) projects. Prof. Alexandre Loupy, a nephrologist specialising in multi-organ transplantation, is one of the 23 French recipents selected in this highly competitive European call for projects. The Consolidator Grant is in recognition of Professor A. Loupy’s internationally acclaimed medical and scientific career, who for almost 15 years has devoted his research to transplant-related issues. In particular related to graft rejection, precision medicine and the prediction of risk of graft loss and death, as well as the optimisation of graft allocation.
![](https://u-paris.fr/wp-content/uploads/2023/05/FG16143-2_photo-Alexandre-Loupy.jpg)
Professor Alexandre Loupy
Alexandre Loupy, is a nephrologist with two doctoral theses in basic science and epidemiology/biostatistics. He is a professor at Université Paris Cité and currently Director of the Paris Transplant Group within PARCC (Université Paris Cité – Inserm) as well as at the Paris Institute for Transplantation and Organ Regeneration (PITOR) at Université Paris Cité. Through the new PITOR Institute, which he has been directing since 2022, he is expanding the scope of his work by promoting interconnections between experts from several research units with diverse skills, including physicians, epidemiologists, statisticians, mathematicians, engineers and bioinformaticians, to improve the care of transplant patients.
His innovative multidisciplinary approach has led him and his team to develop and validate the Integrative Box System (iBox). The iBox is a digital biomarker for predicting graft survival and the efficacy of immunosuppressive treatments at an early stage of transplantation. This AI-based tool, encapsulated in a medical decision support software solution, not only improves the management of kidney transplant patients, but also facilitates the coordination of outpatient and inpatient care. The iBox, a result of close collaboration between AP-HP, Inserm and Université Paris Cité, is supported by all the international learned societies and widely distributed in Europe and the United States, with over 44 participating centers among the most prestigious universities and more than 35,000 patients on 4 continents.
The funding granted by the European Research Council, as part of the Consolidator Grant call for projects, will focus on:
- a simple blood test to quantify circulating donor DNA thus avoiding graft biopsies and reducing invasive procedures for patients, while optimising the detection of organ rejection.
- developing tools based on innovative artificial intelligence technologies, for precision diagnosis of organ rejection and optimization of treatment.
- using innovative approaches in xenotransplantation, by transferring the expertise acquired in humans with the first xenografts of genetically modified pig kidneys into human recipients.
The team’s work and innovative tools will be tested at the Paris Cardiovascular Research Center (PARCC), where the team is based, on the Precision Pathology for Transplantation platform. The platform specialises in the processing of biological samples of all types (blood, plasma, serum, tissue) and is equipped with the innovative technologies and diagnostic platforms to implement the study’s objectives.
Contact press : presse@u-paris.fr
Read more
![Evidence of magmatically induced faults at the East Pacific Rise](https://u-paris.fr/wp-content/uploads/2024/06/Header-1571x711-1080x675.jpg)
Evidence of magmatically induced faults at the East Pacific Rise
By comparison of ultra-high-resolution 3-D seismic imagery and bathymetry data collected at the East Pacific Rise (EPR) 9º50'N, researchers reveal the existence of magmatic induced faults near the ridge axis.
read more![Convergences: A Strategic Alliance paving the Future of Biology-Health Research](https://u-paris.fr/wp-content/uploads/2024/06/IPxUPCite_1920x1080-1-1080x675.jpg)
Convergences: A Strategic Alliance paving the Future of Biology-Health Research
A key milestone for the partnership between Institut Pasteur and Université Paris Cité, the first “Convergences” scientific seminar took place on June 17th at the university’s head office at Odéon.
read more![Université Paris Cité receives 2 grants from Marie Sklodowska Curie Actions programme !](https://u-paris.fr/wp-content/uploads/2024/06/Image-OCEANS-1080x675.jpg)
Université Paris Cité receives 2 grants from Marie Sklodowska Curie Actions programme !
The results of the MSCA Staff Exchange 2023 call for proposals were published on May 28 2024. Université Paris Cité congratulates its two winners, Sylvain Chaty, Professor and Vice President for Culture, Science and Society at the AstroParticle and Cosmology...
read more![MENTOR: Winner of the MSCA Doctoral Networks 2023](https://u-paris.fr/wp-content/uploads/2024/05/Photographie-Mario-Pende-1080x675.jpg)
MENTOR: Winner of the MSCA Doctoral Networks 2023
When abnormally activated, the mTOR protein can contribute to the development of cancers and certain monogenic diseases that affect around 2 million people worldwide. The multi-disciplinary MENTOR project, which stands for Metabolic control of cell growth by mTOR in...
read more